News

Open Public Consultation: Updated SRIA for European Water4All Partnership

Published on | 1 year ago

Programmes
Agro-Food, Environment Missions

Open Public Consultation on the updated Strategic Research and Innovation Agenda (SRIA) for the European Water4All partnership.

The SRIA of the Water4All Partnership will be updated in 2025. As part of the update process, a public consultation on the topics of the Water4All SRIA is launched. The primary objective is to gather perspectives from stakeholders on the scientific scope of Water4All, who may be interested in taking part in this process. Given the strong involvement of Flemish R&I actors, your input would be most appreciated.

To participate: follow this link until Wednesday 11 September 2024.

Also relevant: On 12th September the third Water4all call on "Water and Circular Economy" will be open. You can find more information on this call via this link. 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1824 articles available search in articles 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.